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Objective: Our objective was to assess the prevalence of
accompanying symptoms of migraine and tension-type headache
in patients with such conditions (both episodic and chronic) and
in headache-free controls, and their relationship with depression
and anxiety. Method: A psychological assessment (Axis I, DSM-
IV) was performed, and 21 accompanying symptoms were
investigated in 506 patients with episodic migraine (231), chronic
migraine (102), episodic tension-type headache (83), and chronic
tension-type headache (90) and in 80 controls. The relationship
between symptoms, headache type, and psychiatric comorbidity0022-3999/06/$ – see front matter D 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.jpsychores.2006.03.005
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E-mail address: franco.mongini@unito.it (F. Mongini).was analyzed. Results: The mean number of symptoms was
significantly higher in patients (n=10.3) than in controls (n=3.4).
Most symptoms were significantly associated with depression
and anxiety, while only some of them were significantly
associated with headache, with no relevant difference among
groups. Conclusion: In headache patients, psychiatric comorbid-
ity (compared with headache type or chronicity) seems to be
more strictly associated with an increased burden of accompany-
ing symptoms.
D 2006 Elsevier Inc. All rights reserved.Keywords: Migraine; Tension-type headache; Depression; Anxiety; Accompanying symptomsIntroduction
It is well known that headache is frequently accom-
panied by physical and psychiatric complaints. Likewise,
the association between headache and psychiatric disorders
(the most common being between headache and depression
and anxiety) has been extensively explored [1–3], as
demonstrated by epidemiological and prospective studies
[4–12]. Furthermore, subjects with a combination of
anxiety disorders and major depression are more likely
to have migraine compared with those with depression or
anxiety only [3,13]. The relationship between headache
and depression and/or anxiety disorders seems to be
bidirectional [4,5,8,13], and recent evidence suggests thatsuch disorders may influence headache history in the long
term [9].
Patients suffering from different headache types usually
complain of numerous accompanying symptoms (behav-
ioral and somatic), which may be partially related to
psychiatric comorbidity [14], in particular to anxiety and
mood disorders (Axis I, DSM-IV). In a previous study [15],
somatic symptoms were demonstrated to be more common
in patients with chronic migraine [CM; considered by the
authors as a combined diagnostic category encompassing
transformed migraine, migraine with tension-type headache
(if z15 headache days/month), and new daily persistent
headache] and what they referred to as chronic daily
headache (if z15 headache days/month but not fulfilling
criteria for CM). The symptoms were more common in the
presence of a higher frequency of severe headaches, and
with depression or anxiety, diagnosed on the basis of
clinical impression or self-report [15]. However, the authors
could not distinguish any specific pattern of symptomsearch 61 (2006) 447–451
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of psychiatric comorbidities were made clinically rather than
by a standardized interview.
The purposes of this study were: (a) to investigate the
prevalence of accompanying symptoms in patients with
migraine and tension-type headache (both episodic and
chronic) compared to that in normal controls; and (b) to assess
the extent to which the symptoms were associated with head-
ache type and/or to comorbid mood and anxiety disorders.Method
Patients
Five hundred six patients consecutively referred to the
Unit of Headache–Facial Pain, Department of Clinical
Pathophysiology, University of Turin (Turin, Italy) and
fulfilling the International Headache Society (IHS) diag-
nostic criteria [16] for episodic migraine (EM), episodic
tension-type headache (ETTH), CM, and chronic tension-
type headache (CTTH) were enrolled. The chronic forms
(CM and CTTH) were those characterized by a headache
frequency higher than 15 days/month for at least 3 months
[16]. Exclusion criteria were (a) the presence of other
comorbid major medical illnesses (acute or chronic inflam-
matory disorders and endocrine, nervous, cardiovascular,
liver, and kidney diseases) superimposing on the headache
and (b) medication overuse, according to IHS criteria [16].
Patient distribution was as follows: 231 had EM (22 men,
209 women), 83 had ETTH (13 men, 70 women), 102 had
CM (6 men, 96 women), and 90 had CTTH (14 men,
76 women). Eighty headache-free controls (10 males,
70 females), without mood and anxiety disorders, were also
recruited; their mean age (42.4F11.7 years) was not
significantly different (PN.05, Student’s t test) from that
of patients (39.2F14.0 years).Table 1
Age (meanFS.D.), psychiatric comorbidity (number and percentage of patients)
groups and in controls
EM (n=231;
22 M, 209 F)
ETTH (n=83;
13 M, 70 F)
Age (years) 40.3F13.3 37.5F14
Depression 37 (16%) 13 (16%)
Anxiety 35 (15%) 15 (18%)
Anxiety+depression 48 (21%) 7 (8%)
Total psychiatric comorbidity 120 (52%)4 35 (42%)4
Number of symptoms (All) 10.32F5.29 9.45F4.58
Number of symptoms (WO) 7.32F4.26444 7.44F4.07444
Number of symptoms (W) 13.01F4.86444 12.2F3.77444
M=males; F=females; All=all patients; W=patients with depression or anxiety or
4 v2= 48.81, df=3, Pb.0001, chi-square analysis of the different prevalences
44 Pb.001, F=29.8, df=4, 582, one-way ANOVA (Bonferroni test used to co
the controls).
444 Pb.0001 [Mann–Whitney Rank Sum test used to compare, in each grou
(WO) depression or anxiety.Measures
After giving informed consent, every patient underwent
a neurological examination and a psychological assessment
on Axis I (anxiety, mood, and somatoform disorders) DSM-
IV by means of a structured interview (Structured Clinical
Interview for DSM-IVAxis I Disorders) [17]. The presence
of accompanying symptoms (behavioral or somatic) was
then investigated with a semistructured interview, using a
checklist of 21 items. These items, on a previous study [18],
had shown a significantly different prevalence when used
for screening among healthy subjects and groups of patients
suffering from hormonal, vascular, neurological, and
psychiatric disorders. Each symptom was considered
positive if claimed as habitual or was significantly present
in the last 6 months such that it was remembered as
annoying by the patient. We considered oral parafunctions
(such as tooth grinding, clenching, lip biting, and nail
biting) as habits. Circulatory disorders were peripheral
vascular or capillary circulation disorders. The same semi-
structured interview, with the checklist of 21 items, was also
administered to the controls.
Statistical methods
The prevalence of depression and anxiety was assessed
in the four headache diagnostic groups (EM, ETTH, CM,
and CTTH) and compared by chi-square test.
The mean numbers of symptoms were compared among
the headache groups and the control group by means of one-
way analysis of variance (ANOVA), with Bonferroni test for
multiple comparisons among groups (differences with
P values b.05 were considered as statistically significant).
Then, within each headache group, the numbers of symp-
toms were compared in patients with and in patients without
psychiatric comorbidity (depression and/or anxiety) by
means of Mann–Whitney U test., and number of symptoms (meanFS.D.) in EM, ETTH, CM, and CTTH
CM (n=102;
6 M, 96 F)
CTTH (n=90;
14 M, 76 F)
Controls (n=80;
10 M, 70 F)
39.7F13.8 38F14 42.4F11.7
35 (35%) 13 (14%) _
31 (30%) 21 (23%) _
16 (15%) 22 (25%) _
82 (80%)4 56 (62%)4 _
11.33F4.98 10.09F4.87 3.95F3.3344
7.30F4.56444 7.78F4.38444
12.51F4.48444 11.63F4.59444
both; WO=patients without depression or anxiety.
of psychiatric comorbidity across the four diagnostic groups.
mpare the mean number of symptoms among the four headache groups and
p, the mean number of symptoms between patients with (W) and without
Table 2
Prevalence (%) of accompanying symptoms in EM, ETTH, CM, and CTTH
groups and in controls, with the results of the chi-square test used to
compare the headache patients (EM, ETTH, CM, and CTTH together) and
the controls (CONT)
Symptoms
Prevalence
PEM ETTH CM CTTH CONT
Colitis 38.1 39.3 42.2 35.6 22.5 .0057
Gastritis 47.6 39.3 48.0 43.3 17.5 b.001
Swallowing difficulties 22.5 22.6 26.5 23.3 10.0 .013
Digestion difficulties 33.3 31.0 26.5 32.2 13.8 .0022
Anorexia/bulimia 20.0 19.1 34.3 21.2 6.3 .0006
Phobias 32.9 35.7 35.3 37.8 11.3 b.001
Sleep disorders 57.6 54.8 63.7 55.6 31.3 b.001
Palpitations 49.4 51.2 59.8 54.4 15.0 b.001
Panic attacks 23.8 28.6 25.5 28.9 6.3 b.001
Fainting 9.1 10.7 16.7 10.0 3.8 .1128
Dizziness 40.7 38.1 52.9 41.1 11.3 b.001
Tinnitus 19.5 8.3 22.5 16.7 8.8 .0509
Weariness 66.7 51.2 75.5 65.6 22.5 b.001
Oral parafunctions 59.0 51.2 38.2 60.0 20.0 b.001
Cramps 34.6 22.6 44.1 44.4 15.0 b.001
Paresthesias 39.8 28.6 39.2 36.7 13.8 b.001
Back pain 61.0 66.7 66.7 60.0 31.3 b.001
Urinary disorders 10.4 4.8 16.7 5.6 2.5 .2117
Nail/hair fragility 54.6 46.4 61.8 44.5 15.3 .0091
Circulation disorders 22.9 17.9 36.3 18.9 18.8 .3228
Vaginism/frigidity 17.3 17.8 28.5 12.2 1.3 b.001
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assessed in each headache diagnostic group and in controls.
The difference between headache patients and controls was
evaluated by chi-square test.Table 3
Logistic regression model results [odds ratio (OR) with confidence interval (CI
(PSYCH) as independent variables and with the prevalence of each symptom as
Symptoms
EM ETTH C
OR CI OR CI O
Colitis 1.521 0.812–2.846 1.752 0.862–3.559 1
Gastritis 3.232 1.667–6.268 2.486 1.180–5.239 2
Swallowing difficulties 1.404 0.597–3.303 1.612 0.632–4.113 1
Digestion difficulties 1.517 0.718–3.206 1.584 0.690–3.635 1
Anorexia/bulimia 1.972 0.711–5.469 2.030 0.669–6.161 2
Phobias 2.298 1.047–5.042 2.963 1.263–6.950 2
Sleep disorders 1.777 1.001–3.154 1.823 0.937–3.547 1
Palpitations 2.665 1.320–5.378 3.495 1.605–7.610 3
Panic attacks 1.179 0.678–5.209 2.962 1.016–8.839 2
Fainting 2.005 0.550–7.302 2.563 0.644–10.192 2
Dizziness 3.785 1.751–8.180 3.725 1.605–8.646 3
Tinnitus 1.570 0.634–3.886 0.642 0.205–2.008 1
Weariness 3.664 1.971–6.810 2.164 1.064–4.403 3
Oral parafunctions 3.193 1.689–6.037 3.058 1.492–6.266 3
Cramps 2.170 1.069–4.402 1.288 0.565–2.939 3
Paresthesias 2.570 1.243–5.312 1.710 0.750–3.896 2
Back pain 2.220 1.250–3.942 3.291 1.671–6.481 2
Urinary disorders 2.956 0.638–13.695 1.386 0.236–8.150 1
Nail/hair fragility 1.762 0.789–3.933 1.581 0.640–3.904 1
Circulation disorders 0.858 0.426–1728 0.643 0.298–1.572 0
Vaginism /frigidity 7.607 0.996–58.118 9.958 1.212–76.974 4
Significant values are in boldface.Eventually, logistic regression models were applied to
evaluate the association of each symptom with diagnostic
categories and with psychiatric comorbidity (anxiety and/or
depression), taking EM, ETTH, CM, and CTTH groups and
psychiatric comorbidity as independent variables and the
prevalence of each symptom as a dependent variable.Results
Demographic characteristics, the prevalence of psychi-
atric comorbidity, and the number of symptoms in the four
headache diagnostic groups and in controls are shown in
Table 1. The prevalence of depression and/or anxiety was
elevated in all headache groups, particularly in chronic
headache types. The prevalence of psychiatric comorbidity
ranged from a minimum of 42% in ETTH patients to a
maximum of 80% in CM patients. Anxiety disorders were
represented by generalized anxiety disorders in 95% of the
cases and by panic disorders or agoraphobia in only 5% of
the cases. Depressive disorders were represented by major
depression in 86% of the cases and dysthymic disorder in
14% of the cases. The distributions of these two disorders
were similar among the diagnostic groups. The low
number or the absence of other specific anxiety and mood
disorders in our files may be attributed to the fact that
patients with these disorders are more frequently referred
directly to a psychiatric institution.
Chi-square analysis across the four diagnostic groups
(Table 1) showed a significant difference in the prevalence)], with EM, ETTH, CM, and CTTH groups and psychiatric comorbidity
dependent variable (the control group being a covariate)
M CTTH PSYCH
R CI OR CI OR CI
.311 0.635–2.706 1.571 0.761–3.239 1.817 1.242–2.658
.631 1.244–5.564 2.914 1.371–6.194 1.677 1.161–2.423
.377 0.533–3.557 1.393 0.540–3.590 2.806 1.753–4.491
.319 0.568–3.062 0.809 0.341–1.920 3.457 2.250–5.310
.021 0.667–6.126 3.363 1.140–9.924 2.287 1.397–3.743
.702 1.144–6.389 2.078 0.869–4.970 2.471 1.656–3.689
.522 0.775–2.989 1.810 0.910–3.600 2.722 1.870–3.962
.032 1.380–6.663 2.987 1.348–6.621 3.879 2.644–5.690
.265 0.764–6.712 1.511 0.502–4.548 4.303 2.652–6.982
.171 0.532–8.860 3.653 0.936–14.253 1.531 0.832–2.817
.699 1.587–8.624 5.382 2.306–12.562 1.901 1.308–2.763
.228 0.439–3.428 1.585 0.579–4.338 2.225 1.326–3.735
.169 1.535–6.540 4.125 1.944–8.751 3.704 2.491–5.508
.463 1.676–7.153 1.308 0.619–2.761 2.010 1.384–2.920
.185 1.458–6.958 2.842 1.288–6.271 1.785 1.210–2.633
.112 0.936–4.768 2.042 0.900–4.629 2.361 1.597–3.492
.010 1.024–3.948 2.315 1.160–4.619 2.344 1.602–3.430
.427 0.250–8.154 4.389 0.882–21.842 2.026 1.029–3.988
.296 0.515–3.263 2.678 1.109–6.468 1.725 1.108–2.683
.639 0.277–1.474 1.413 0.644–3.100 2.017 1.283–3.172
.958 0.593–41.428 10.936 1.373–87.109 2.292 1.308–4.014
F. Mongini et al. / Journal of Psychosomatic Research 61 (2006) 447–451450of psychiatric comorbidity (highest in CM and lowest in
ETTH; v2=48.81, df=3, Pb.0001).
The mean number of symptoms was significantly higher
(Pb.001, F=29.8, df=4, 582) in headache patients than in
controls, but it was not statistically different (P=.08) among
the four headache groups. Moreover, in each headache
group, it was significantly higher in patients with psychiatric
comorbidity (depression or anxiety, or both) than in those
without psychiatric comorbidity (Pb.0001).
The prevalence of accompanying symptoms in the four
diagnostic groups and in controls, with the results of the chi-
square test, is reported in Table 2. As observable, most
symptoms were significantly more prevalent in all headache
subjects than in controls.
The logistic regression models (Table 3) demonstrated a
significant association of all symptoms (except fainting and
urinary disorders) with psychiatric comorbidity (anxiety
and/or depression). The relationship between symptoms and
headache was found to be significant for gastritis, phobias,
palpitations, dizziness, weariness, oral parafunctions,
cramps, back pain, and sexual disturbances, with very few
differences across the four diagnostic categories.Discussion
Our results demonstrate an overwhelmingly (more than
twofold) higher number of accompanying symptoms in a
large and homogeneous cohort of patients with migraine and
tension-type headache (both episodic and chronic) than in
headache-free controls (Table 1). Psychiatric comorbidity
was generally quite elevated. In particular, a significantly
higher prevalence of psychiatric comorbidity was observed
in chronic forms with respect to episodic ones, most
especially in CM patients, while in episodic headaches,
comorbid psychiatric disorders were more prevalent in
migraine than in tension-type headache (Table 1).
This finding seems to point to a role of mood disorders in
the chronicization process, in agreement with previous
studies showing that, in migraine patients, the relationship
between headache and depression or anxiety disorders is
bidirectional [4,5,8,13] and that such disorders may
influence headache history in the long term [9].
A significantly higher prevalence of most symptoms was
detected in headache patients. This increased burden of
physical complaints in headache patients may be, at least
partly, subsequent to, or influenced by, an increased attention
to bodily sensations or may be inherent to the pain disorder.
Indeed, a high prevalence of sleep, bowel disturbances, and
fatigue frequently occurs in chronic pain disorders, most
likely fibromyalgia, and may reflect underlying pathophysio-
logical mechanisms that are as yet poorly understood.
Nevertheless, the significantly higher number of symptoms
in patients with psychiatric comorbidity and, above all, the
results of the logistic regression models strongly suggest a
role of depression and anxiety in the presence of accompany-ing symptoms. In fact, we detected a significant association
between the majority of symptoms (all but fainting and
urinary disorders) and psychiatric comorbidity (Table 3). This
finding, consistent with the findings of previous authors [15]
that found somatic symptoms to be more common in patients
with associated depression or anxiety, clearly hints at the
involvement of psychiatric comorbidity in the expression of
physical complaints. Nevertheless, some symptoms appeared
to be significantly related to the presence of headache as well.
Since they were generally associated with migraine and
tension-type headache (whether episodic or chronic), it seems
that the presence of headache, more than its diagnostic
category or course, plays a role in affecting a given amount
of physical complaints. The pathophysiological background
of the association between some symptoms and headache
is difficult to clarify. Regarding oral parafunctions, we may
hypothesize the possible role of muscular tenderness as a
common mechanism involved in the complex pathophysiol-
ogy of tension-type headache and in the expression of this
symptom [19–23].
At any rate, our findings suggest that, in headache
patients, psychiatric comorbidity (compared with headache
diagnosis or chronicity) is more strictly associated with an
increased burden of accompanying symptoms. The question
about the role of these factors in affecting the natural history
of headache arises. In the aforementioned study [9], the co-
occurrence of depression and personality changes in women
with migraine seemed to negatively influence headache
course in the long term. More recently, it was observed that,
in patients suffering from EM, anxiety and/or depression
was related to a higher level of tenderness of the pericranial
muscles and, even more, of the cervical muscles [24]. It was
hypothesized that the more elevated muscle tenderness in
migraine patients with psychiatric disorders could be one of
the factors that may influence the history of migraine and
may facilitate its evolution into CM.
The increased burden of accompanying symptoms
detected in this research, above all in subjects suffering
from depression and/or anxiety, could represent another
putative mechanism of influence of psychiatric disorders on
migraine history. Further longitudinal studies are needed to
confirm this hypothesis. In any case, in a clinical point of
view, an accurate investigation of the accompanying
symptoms in headache patients may provide clinicians with
a useful additional tool with which to appraise the potential
presence of a psychiatric comorbidity and to accordingly
adjust treatment strategies.References
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